The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice

被引：21
作者：
Burch, Rebecca C. [1 ]
Ailani, Jessica [2 ]
Robbins, Matthew S. [3 ]
机构：
[1] Harvard Med Sch, Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA
[2] Medstar Georgetown Univ Hosp, Dept Neurol, Washington, DE USA
[3] Weill Cornell Med, Dept Neurol, New York, NY USA
来源：
HEADACHE | 2022年 / 62卷 / 01期
关键词：
American Headache Society; behavioral; calcitonin gene related peptide; consensus statement; migraine; neuromodulation;
D O I：
10.1111/head.14245
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：111 / 112
页数：2
相关论文
共 7 条
  • [1] Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon
    Breen, Ilana D.
    Brumfiel, Caitlin M.
    Patel, Meera H.
    Butterfield, Richard J.
    VanderPluym, Juliana H.
    Griffing, Leroy
    Pittelkow, Mark R.
    Mangold, Aaron R.
    [J]. JAMA NETWORK OPEN, 2021, 4 (04)
  • [2] The American Headache Society Position Statement On Integrating New Migraine Treatments Into Clinical Practice
    Digre, Kathleen B.
    [J]. HEADACHE, 2019, 59 (01): : 1 - 18
  • [3] Anti-CGRP monoclonal antibodies for migraine prevention: A systematic review and likelihood to help or harm analysis
    Drellia, Konstantina
    Kokoti, Lili
    Deligianni, Christina, I
    Papadopoulos, Dimitrios
    Mitsikostas, Dimos D.
    [J]. CEPHALALGIA, 2021, 41 (07) : 851 - 864
  • [4] Raynaud's Phenomenon Associated With Calcitonin Gene-Related Peptide Monoclonal Antibody Antagonists
    Evans, Randolph W.
    [J]. HEADACHE, 2019, 59 (08): : 1360 - 1364
  • [5] Diagnosis and Management of Headache: A Review
    Robbins, Matthew S.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (18): : 1874 - 1885
  • [6] Hypertension: A new safety risk for patients treated with erenumab
    Saely, Suprat
    Croteau, David
    Jawidzik, Laura
    Brinker, Allen
    Kortepeter, Cindy
    [J]. HEADACHE, 2021, 61 (01): : 202 - 208
  • [7] The Emperor's New Gepants: Are the Effects of the New Oral CGRP Antagonists Clinically Meaningful?
    Tfelt-Hansen, Peer
    Loder, Elizabeth
    [J]. HEADACHE, 2019, 59 (01): : 113 - 117
1